newsfilter
← Latest News
GlobeNewswire·

Chemomab Therapeutics to Present at October 2024 Investor Conferences

TEL AVIV, Israel, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (NASDAQ:CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with